Biomarkers for systemic lupus erythematosus: A scoping review
Immunity, Inflammation and Disease · 2024-10 · 12 (10)
DOI: 10.1002/iid3.70022 ↗Kurz gefasst
Scoping Review in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 04.10.2024. Verfasst von Su-Jie Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, Key Laboratory of High…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Biomarkers. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In recent years, newly discovered potential biomarkers have great research potential in the diagnosis, disease activity prediction, and treatment of systemic lupus erythematosus (SLE).
Objective
In this study, a scoping review of potential biomarkers for SLE over several years has identified the extent to which studies on biomarkers for SLE have been conducted, the specificity, sensitivity, and diagnostic value of potential biomarkers of SLE, the research potential of these biomarkers in disease diagnosis, and activity detection is discussed.
Methods
In PubMed and Google Scholar databases, “SLE,” “biomarkers,” “predictor,” “autoimmune diseases,” “lupus nephritis,” “neuropsychiatric SLE,” “diagnosis,” “monitoring,” and “disease activity” were used as keywords to systematically search for SLE molecular biomarkers published from 2020 to 2024. Analyze and summarize the literature that can guide the article.
Conclusions
Recent findings suggest that some potential biomarkers may have clinical application prospects. However, to date, many of these biomarkers have not been subjected to repeated clinical validation. And no single biomarker has sufficient sensitivity and specificity for SLE. It is not scientific to choose only one or several biomarkers to judge the complex disease of SLE. It may be a good direction to carry out a meta‐analysis of various biomarkers to find SLE biomarkers suitable for clinical use, or to evaluate SLE by combining multiple biomarkers through mathematical models. At the same time, advanced computational methods are needed to analyze large data sets and discover new biomarkers, and strive to find biomarkers that are sensitive and specific enough to SLE and can be used in clinical practice, rather than only staying in experimental research and data analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, Key Laboratory of High Altitude Environment and Genes Related to Diseases of Tibet Autonomou…
ORCID-Profile: Rui-Yang Xu, Long-Li Kang
Zitieren
APA
Zhang, S. J., Xu, R. Y., & Kang, L. L. (2024). Biomarkers for systemic lupus erythematosus: A scoping review. Immunity, Inflammation and Disease, 12(10). https://doi.org/10.1002/iid3.70022
Vancouver
Zhang SJ, Xu RY, Kang LL. Biomarkers for systemic lupus erythematosus: A scoping review. Immunity, Inflammation and Disease. 2024;12(10). doi:10.1002/iid3.70022
BibTeX
@article{Zhang2024,
author = {Zhang, Su-Jie and Xu, Rui-Yang and Kang, Long-Li},
title = {Biomarkers for systemic lupus erythematosus: A scoping review},
journal = {Immunity, Inflammation and Disease},
year = {2024},
volume = {12},
number = {10},
doi = {10.1002/iid3.70022}
}
EUVIMED